Investigating the role of ficolin-2 in carotid stenosis and brain inflammation
Official title: Plaque and Brain Inflammation in Symptomatic Carotid Stenosis: Role of the Ficolin-2
Run by Hospices Civils de Lyon · NCT05850247 · Data updated 2026-11-12
This study is testing if a specific biomarker can help identify dangerous plaque in the carotid artery of patients who have had a mini-stroke or stroke, to see if they might benefit from a procedure to improve blood flow.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Bron) |
| Status | Recruiting |
| Started | February 13, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | February 6, 2025 |
| Trial ID | NCT05850247 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and over who have experienced a recent transient ischemic attack, retinal artery occlusion, or ischemic stroke and have significant carotid stenosis.
✕Probably not a fit
Patients with inflammatory or autoimmune diseases, active malignancies, or recent major surgeries may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to explore the relationship between plaque composition in carotid artery stenosis and the risk of ischemic stroke, focusing on the biomarker ficolin-2. It will involve patients who have experienced a transient ischemic attack, retinal artery occlusion, or ischemic stroke, and who have significant carotid stenosis. The study will utilize [18F]DPA-714 PET/MRI imaging to assess the state of the plaques and their inflammatory status. By identifying vulnerable plaques, the trial seeks to determine which patients may benefit from carotid revascularization.
Why it matters
Potential benefit: If successful, this study could lead to improved identification of patients at high risk for stroke, allowing for timely and targeted interventions.
How similar studies have gone: While the specific approach of using ficolin-2 as a biomarker in this context is novel, there is existing evidence supporting the role of the complement system in atherosclerosis.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients 18 years or over, * Signed written informed consent before any study specific intervention, * Probable ipsilateral transient ischemic attack (TIA - which involve a focal speech/language, motor or visual deficit referable to the distribution of a carotid artery and lasting less than 48 hours from the onset) OR retinal artery occlusion ≤ 48h OR ischemic stroke ≤ 48h from the onset, * Atherosclerotic carotid stenosis between 50% and 99% (NASCET method), as confirmed by one of the imaging examinations (among: Doppler ultrasound, MR angiography, CT angiography, catheter angiography) performed after index TIA or ischemic stroke * No other identified cause of TIA, ischemic stroke or retinal artery occlusion, Exclusion Criteria: * Patients with inflammatory or autoimmune disease, hepatocellular insufficiency, acute or chronic infection, active malignancy, myocardial infarction or major surgery within the previous 30 days of index hospitalization according to the investigator, * Patients with severe renal insufficiency (estimated GFR \< 30 ml/min at inclusion or known dialysis), * Patients with contraindication to MRI (agitation, claustrophobia, pacemaker, metallic (ferromagnetic) body, a known allergy to gadolinium) according to the investigator's judgment, * Patients with modified Rankin score greater than 3, * Patients currently enrolled in another clinical trial including investigational medicinal products, * Female patient who is pregnant or lactating, or is of child-bearing and who did not agree to use highly effective methods of birth control throughout the study, * Patient without health coverage, * Patient under legal protection
Where it's running
-
Service de Neurologie vasculaire / CarMeN U1060 INSERM Hôpital Neurologique Pierre Wertheimer - GHE
Bron, France Recruiting
Study contacts
- Principal investigator: Laura MECHTOUFF — Service de Neurologie vasculaire / CarMeN U1060 INSERM
- Study coordinator: Laura MECHTOUFF
- Email: laura.mechtouff@chu-lyon.fr
- Phone: 4.27.85.67.47
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Will GFAP in the blood after carotid endarterectomy predict neurological problems?
This study tests whether blood GFAP levels before and after carotid endarterectomy relate to postoperative neurological issues in adults.
-
Remote arm‑cuff conditioning plus stent placement for symptomatic carotid narrowing
This study tests whether regular remote limb ischemic conditioning after carotid artery stenting can lower major vascular events and improve outcomes for adults with symptomatic carotid artery narrowing.
-
Residual and recurrent carotid narrowing after endarterectomy with primary closure
The study will test how often and when carotid narrowing comes back after elective carotid endarterectomy with primary closure in adults.
-
Managing asymptomatic carotid stenosis to prevent strokes
This study looks at whether surgery to clear blocked neck arteries can help older patients with no symptoms avoid strokes.
-
Selective coronary revascularization for patients with carotid artery disease after carotid surgery
This study is testing if adding a specific heart procedure to the best medical treatment can help prevent heart problems in patients over 50 who have had surgery for carotid artery disease.
-
Carotid artery stenting during treatment of acute stroke
This study is testing if adding carotid artery stenting during a stroke treatment can help improve blood flow to the brain and lower the chances of having another stroke for patients with blocked carotid arteries.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.